Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Chief Executive Officer sold 3,650 shares at $15.02 ($54,829)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $16.26 ($812,859)
  12. 4 Open-market sale Chief Executive Officer sold 616 shares at $16.92 ($10,426)
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Chief Executive Officer sold 49,384 shares at an average $16.30 ($805,183)
  15. 4 Open-market sale Chief Legal Officer sold 1,852 shares at $16.61 ($30,753)
  16. 4 Open-market sale Chief Business Officer sold 5,481 shares at an average $16.76 ($91,839)
  17. 4 Open-market sale Chief Legal Officer sold 21,639 shares at an average $16.78 ($363,077)
  18. 4 Open-market sale Chief Legal Officer sold 11,332 shares at an average $16.78 ($190,109)
  19. 4 Open-market sale Chief Business Officer sold 11,615 shares at an average $16.78 ($194,942)
  20. 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $17.88 ($893,918)

Page 23 of 26 · 502 filings